Effects of EGFR Inhibitors on Proton Pump Function in Gastric Mucosa and Its Mechanism
DOI:
https://doi.org/10.62051/ijphmr.v1n3.08Keywords:
EGFR inhibitor, Proton pump, Gastric acid secretion, Signaling pathwayAbstract
This research was carried out to detect the influence of the proton pump mechanism function on the EGFR inhibitor. Human gastric cancer cell line MKN-45 cells were divided into different concentrations of EGFR inhibitors and treated with either AG1478 or PD153035. Western Blot and immunofluorescence describe the expression of proton pump (H+/K+ ATPase). Next, the phosphorylated levels of ERK and AKT were analyzed. The overall disruption and strong results in the effects of EGFR inhibition, proton-pump transcription, and phosphorylation of ERK and AKT indicated the vital importance of this pathway. Moreover, this study also indicated that EGFR inhibitors were inhibitors of the EGFR signaling pathways themselves due to a decrease in the expression and activity of the proton pump; moreover, this inhibitory effect was closely related to drug concentration. Such findings open up new treatment opportunities for various gastric diseases and underline the possibly critical role of EGFR in gastric acid regulation.
References
Becker, J. C., Grosser, N., Waltke, C., Schulz, S., Erdmann, K., Domschke, W., & Schröder, H. (2006). Beyond gastric acid reduction: proton pump inhibitors induce heme oxygenase-1 in gastric and endothelial cells. Biochemical and biophysical research communications, 345(3), 1014-21.
Cho, H., Chun, H., Keum, B., Kim, Y., Jeen, Y., Seo, Y., Lee, H., Um, S., Kim, C., & Ryu, H. (2011). Ethanol-induced DNA damage and the expression of repair-related molecules in human gastric carcinoma AGS cells with use of an acid pump antagonist and proton pump inhibitor. Journal of clinical oncology: official journal of the American Society of Clinical Oncology, 29(4_suppl), 30.
Hritz, I., Herszényi, L., Molnár, B., Tulassay, Z., & Prónai, L. (2005). Long-term omeprazole and esomeprazole treatment does not significantly increase gastric epithelial cell proliferation and epithelial growth factor receptor expression and has no effect on apoptosis and p53 expression. World journal of gastroenterology, 11(30), 4721-6.
Bianco, R., Gelardi, T., Damiano, V., Ciardiello, F., & Tortora, G. (2007). Mechanisms of resistance to EGFR inhibitors. Targeted Oncology, 2, 31-37.
Kobayashi, S. S., Boggon, T., Dayaram, T., Jänne, P., Kocher, O., Meyerson, M., Johnson, B., Eck, M., Tenen, D., & Halmos, B. (2005). EGFR mutation and resistance of non-small-cell lung cancer to gefitinib. The New England journal of medicine, 352(8), 786-92.
Cortot, A., Repellin, C., Shimamura, T., Capelletti, M., Zejnullahu, K., Ercan, D., Christensen, J., Wong, K., Gray, N., & Jänne, P. (2013). Resistance to irreversible EGF receptor tyrosine kinase inhibitors through a multistep mechanism involving the IGF1R pathway. Cancer research, 73(2), 834-43.
Tandon, R., Kapoor, S., Vali, S., Senthil, V., Nithya, D., Venkataramanan, R., Sharma, A., Talwadkar, A., Ray, A., & Bhatnagar, P. (2011). Dual epidermal growth factor receptor (EGFR)/insulin-like growth factor-1 receptor (IGF-1R) inhibitor: a novel approach for overcoming resistance in anticancer treatment. European journal of pharmacology, 667(1-3), 56-65.
Chen, X. (2007). Mechanisms of resistance to EGFR inhibitors. Journal of Pharmaceutical Research.
Ciardiello, F., & Tortora, G. (2008). EGFR antagonists in cancer treatment. The New England journal of medicine, 358(11), 1160-74.
Chen, L., Fu, W., Zheng, L., Liu, Z., & Liang, G. (2017). Recent Progress of Small-Molecule Epidermal Growth Factor Receptor (EGFR) Inhibitors against C797S Resistance in Non-Small-Cell Lung Cancer. Journal of medicinal chemistry, 61(10), 4290-4300.
Wheeler, D., Dunn, E. F., & Harari, P. (2010). Understanding resistance to EGFR inhibitors—impact on future treatment strategies. Nature Reviews Clinical Oncology, 7, 493-507. Link
Lacouture, M. (2006). Mechanisms of cutaneous toxicities to EGFR inhibitors. Nature Reviews Cancer, 6, 803-812.
Downloads
Published
Issue
Section
License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.